Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Financial Results:
Solara Active Pharma Sciences Ltd reported Revenues for Q2FY24 of ₹425.00 Crores up from ₹338.00 Crore year on year, a rise of 25.74%.
Total Expenses for Q2FY24 of ₹438.00 Crores up from ₹362.00 Crores year on year, a rise of 20.99%.
Consolidated Net Profit of -₹17.00 Crores from -₹10.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹4.77, from -₹2.77 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.